Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Repligen Corp (NASDAQ:RGEN)

Friday’s trading has closed, but RGEN is being traded in the after-hours session. After-Hours quote »
22.97
Delayed Data
As of 4:00pm ET
 +1.24 / +5.71%
Today’s Change
20.07
Today|||52-Week Range
42.48
-18.81%
Year-to-Date
No recent news for Repligen Corp.

Today’s Trading

Previous close21.73
Today’s open22.22
Day’s range21.40 - 23.03
Volume379,664
Average volume (3 months)373,260
Market cap$715.9M
Dividend yield--
Data as of 4:00pm ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)-50.00%
Earnings growth (this year)+36.00%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-6.78%
P/E ratio89.0
Price/Sales10.36
Price/Book6.37

Competitors

 Today’s
change
Today’s
% change
CLVSClovis Oncology Inc+0.37+1.99%
ZIOPZIOPHARM Oncology In...+0.10+1.82%
DERMDermira Inc-2.17-9.19%
DVAXDynavax Technologies...+0.06+0.32%
Data as of 4:00pm ET, 02/12/2016

Financials

Next reporting dateMarch 11, 2016
EPS forecast (this quarter)$0.07
Annual revenue (last year)$63.5M
Annual profit (last year)$8.2M
Net profit margin12.86%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive &
Operating Officer
Tony J. Hunt
Chief Financial Officer
Jon K. Snodgres
Corporate headquarters
Waltham, Massachusetts

Forecasts

Partner Offers